Expand PTGX Menu
PTGX MENU

PTGX Latest Press Releases

-- March 18, 2026 --

Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis ACCESS Newswire 8:05 AM

-- March 2, 2026 --

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera Business Wire 2:00 AM

-- February 25, 2026 --

CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update ACCESS Newswire 5:15 PM
Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update ACCESS Newswire 4:05 PM

-- February 24, 2026 --

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026 ACCESS Newswire 7:30 AM

-- January 7, 2026 --

Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026 ACCESS Newswire 7:30 AM

-- January 5, 2026 --

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV) Business Wire 7:00 AM

-- December 6, 2025 --

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera Business Wire 9:30 AM

-- November 27, 2025 --

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice ACCESS Newswire 3:45 AM

-- November 6, 2025 --

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire 4:05 PM

-- November 3, 2025 --

Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting ACCESS Newswire 4:05 PM

-- October 27, 2025 --

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences ACCESS Newswire 7:35 AM
Market Data Delayed 15 Minutes